Clinical trial
Occluded Artery Trial (OAT)
NCT00004562 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00004562 |
|---|---|
| Title | Occluded Artery Trial (OAT) |
| Official title | Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI |
| Acronym | OAT |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Heart Failure, Congestive |
| Intervention type | Drug, Procedure |
| Interventions | Beta adrenergic blockers, Platelet inhibitors, PTCA and stents, ACE Inhibitors |
| Enrollment | 2,201 |
| Start date | Sep 1, 1999 |
| Primary completion | Mar 1, 2010 |
| Completion | Jun 1, 2011 |
| First posted | Feb 10, 2000 |
| Last update posted | Apr 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: